Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
53 participants
OBSERVATIONAL
2015-09-30
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim of the study is to investigate the muscle involvement in patients with Kennedy disease using MRI. Secondary aims are to examine disease severity and to test MRI as a potential outcome measure for future clinical trials in Kennedy disease.
Approximately 40 patients with Kennedy disease and 20 gender and age matched healthy voluntary controls will be recruited. The study consists of one visit per subject lasting 4-5 hours.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using MRI in Patients With Non-dystrophic Myotonia to Access Muscle Contractility
NCT04808388
Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
NCT02165358
Mechanisms of Cell Death in Spinal Muscular Atrophy
NCT01754441
Contractile Cross Sectional Areas and Muscle Strength in Patients With Congenital Myopathies
NCT03018184
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
NCT04929002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Kennedy disease
Men over 18 years old with confirmed Kennedy disease.
No intervention, observational
Healthy, voluntary controls
Gender and age matched healthy, voluntary controls.
No intervention, observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention, observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fit age and gender criteria
Exclusion Criteria
Healthy controls
* All contraindications for undergoing an MRI scan
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julia Dahlqvist, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia R Dahlqvist, MD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, Copenhagen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen Neuromuscular Center
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
The homepage of Copenhagen Neuromuscular Center, Denmark.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-15006316
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.